Back to Search
VINOD RUSTGI, MD
Gastroenterology Physician
NPI: 1679589121IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
MD-029154E(PA)25MA09823400(NJ)
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1979
Research & Publications (20)
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.
PMID 19061971·Clin Gastroenterol Hepatol·2009
3-trial
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.
PMID 19669251·Hepatol Int·2009
8-other
Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C.
PMID 19275518·Curr Med Res Opin·2009
6-review
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
PMID 18537189·Hepatology·2008
4-observational
Noninvasive monitoring of hepatitis C fibrosis progression.
PMID 18625428·Clin Liver Dis·2008
6-review
Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
PMID 18081737·Aliment Pharmacol Ther·2008
3-trial
Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
PMID 17875007·J Viral Hepat·2007
3-trial
The epidemiology of hepatitis C infection in the United States.
PMID 17653645·J Gastroenterol·2007
6-review
Thymalfasin for the treatment of chronic hepatitis C infection.
PMID 17600289·Ann N Y Acad Sci·2007
8-other
Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.
PMID 17030201·Gastroenterology·2006
8-other
Thymalfasin for the treatment of chronic hepatitis C infection.
PMID 16307501·Expert Rev Anti Infect Ther·2005
6-review
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.
PMID 15546255·J Gastroenterol Hepatol·2004
4-observational
Impact of body mass index on graft failure and overall survival following liver transplant.
PMID 15516235·Clin Transplant·2004
8-other
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.
PMID 15641209·J Gastroenterol Hepatol·2004
3-trial
A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.
PMID 12774016·Hepatology·2003
3-trial
Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease.
PMID 11860406·Aliment Pharmacol Ther·2002
3-trial
Impact of donor age on graft survival among liver transplant recipients: analysis of the United Network for Organ Sharing database.
PMID 12493451·Transplant Proc·2002
4-observational
Role of gender and race mismatch and graft failure in patients undergoing liver transplantation.
PMID 12037781·Liver Transpl·2002
8-other
Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices.
PMID 11927906·Adv Ren Replace Ther·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 125 PATERSON ST STE 5100
NEW BRUNSWICK, NJ 08901 - Phone
- (732) 235-7784
Quick Facts
- NPI
- 1679589121
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile